
|Videos|April 23, 2020
Updates and Considerations for the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic
Advertisement
This OncLive® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from Dana-Farber Cancer Institute led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer.
Topics/Objectives:
- Risk of patients with breast cancer for developing COVID-19
- Best practices in the management of patients with breast cancer that have the novel coronavirus or who may be at risk for developing it
- Expanding use of telemedicine in breast cancer care
- Impact the COVID-19 pandemic has had on testing in patients with breast cancer
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5






































